| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/20/2008 | US7374749 Amino substituted hydroxyphenyl benzophenone derivatives |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2169695C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations and medicaments containing them |
| 05/15/2008 | US20080114169 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
| 05/15/2008 | US20080114036 Novel Compounds, Their Preparations And Use |
| 05/15/2008 | US20080114000 Suppressor of excess accumulation of intracellular sodium ions |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113975 Thiourea compounds |
| 05/15/2008 | US20080113968 Substituted piperazines and diazepanes |
| 05/15/2008 | DE19753655B4 α-Aminoacetophenonverbindungen, Massen, die diese Verbindungen enthalten und deren Verwendung als Photostarter α-Aminoacetophenonverbindungen, compositions containing these compounds and their use as photoinitiators |
| 05/15/2008 | CA2672956A1 Calcium receptor modulating agents |
| 05/14/2008 | EP1919883A1 N-oxides as prodrugs of piperazine&piperidine derivatives |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | CN101180288A Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs |
| 05/14/2008 | CN101177420A Method for intermittent azeotropic rectifying separating N-ethylpiperazine-ethanolamine |
| 05/14/2008 | CN101177419A Method for separating N-ethylpiperazine-ethanolamine azeotropic mixture by azeotropic rectifying intermittent operation |
| 05/14/2008 | CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 05/14/2008 | CN100387581C Process to produce oxazolidinones |
| 05/13/2008 | US7371877 Glycerol ester derivative |
| 05/13/2008 | US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl |
| 05/13/2008 | US7371855 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 05/13/2008 | US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371746 1,2,4-Thiadiazole compounds and pests controlling composition containing the same |
| 05/13/2008 | CA2327854C Plant growth regulator compositions |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053023A1 Crosslinker for vulcanization, process for its preparation and rubber products |
| 05/08/2008 | WO2008052658A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties |
| 05/08/2008 | US20080108618 Compounds with activity on muscarinic receptors |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108595 Inhibitors of cathepsin s |
| 05/08/2008 | US20080107599 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 05/08/2008 | CA2668094A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1917254A2 Process of producing amorolfine |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | CN101175738A Apoptosis promoters |
| 05/07/2008 | CN101175720A New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/07/2008 | CN101172949A Catalytic esterification method for sulfonic group functionalization morpholine hyamine ion liquid |
| 05/06/2008 | US7368605 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/06/2008 | US7368448 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/02/2008 | WO2008051597A1 Process for the preparation of imatinib |
| 05/02/2008 | WO2008050858A1 Amide compound, salt thereof, and biofilm remover using them |
| 05/02/2008 | WO2008049806A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/02/2008 | WO2008049605A1 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/02/2008 | CA2666885A1 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/02/2008 | CA2664141A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/01/2008 | US20080103328 Synthetic and semisynthetic acanthoic acid derivatives; antiinflammatory, anticancer and antitumor agents |
| 05/01/2008 | US20080103140 Cyclohexylamides as Dopamine D3, D2 and 5Ht1a Antagonists |
| 05/01/2008 | US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 05/01/2008 | US20080101989 Methods, Compositions and Kits Pertaining to Analyte Determination |
| 04/30/2008 | EP1915356A1 Therapeutic agents |
| 04/30/2008 | EP1915355A1 Therapeutic agents |
| 04/30/2008 | EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 04/30/2008 | CN101168532A Method for synthesizing N-methylpiperazine substituted anilin |
| 04/29/2008 | US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365075 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/29/2008 | CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2007100506A3 Mass tags for quantitative analyses |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096903 inhibitors of disease-related target, Heat Shock Protein 90 (HSP90); antiproliferative; 2-chloro-5'-sulfamoyladenosine analogs; derivatives of adenine and other purines; Sulfamic Acid 2-[6-amino-2-fluoro-8-(6-iodo-benzo[1,3]dioxol-5-ylmethyl)-purin-9-yl]-ethyl ester |
| 04/24/2008 | US20080096889 Histone Deacetylases Inhibitors |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | US20080096873 New compounds |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/23/2008 | EP1912962A2 Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene |
| 04/23/2008 | EP1912961A2 Process of producing bepromoline |
| 04/23/2008 | EP1912679A2 Amine-containing lipids and uses thereof |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN100383116C Methoximinophenylacetic acid amides |
| 04/22/2008 | US7361771 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 04/22/2008 | US7361685 Compounds for use in the treatment of skin conditions |
| 04/22/2008 | US7361662 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/22/2008 | US7361655 Pharmaceutically effective compounds |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 04/17/2008 | WO2008045671A1 Matrix metalloprotease inhibitors |
| 04/17/2008 | WO2008044033A1 Amide derivatives |
| 04/17/2008 | WO2008043183A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/17/2008 | WO2007143745A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/17/2008 | US20080090839 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation |
| 04/17/2008 | US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | US20080090779 2-Benzyloxy-5-(2-bromoacetyl)-N-[3,5-bis(trifluoromethyl)phenyl-benzamide; diseases caused by production of immunoglobulin E: inflammatory cytokine, histamine, leukotriene and degranulation from activated mast cell; pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis, hysteromyoma |
| 04/17/2008 | CA2666275A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/16/2008 | EP1911762A1 Amino alcohols and their use as renin inhibitors |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |